Home / Expertise / Life Sciences & Healthcare
Lab

Life Sciences & Healthcare

United Arab Emirates

Dubai’s vision to become a hub for healthcare tourism, the rapid expansion of local and expat populations across the Middle East, as well as the region’s unique demographics, give rise to opportunities and challenges for investors in the lifesciences and healthcare sectors.

We work with and have established long-term relationships with the top 100 lifesciences companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.  We also support clinics, hospitals, and other service providers active in the healthcare sector, and private investors in such businesses, across the Middle East. Our experts advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 150 international specialist lawyers across CMS, we understand the scientific and commercial as well as the legal imperatives affecting your lifesciences and healthcare businesses. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the lifesciences sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice.

Read more Read less
High­lights of our ex­per­i­ence in Lifes­ci­ences in UAE

Feed

Show only
CMS Ex­pert Guide to Ad­vert­ising of Medi­cines and Med­ic­al...
22 May 20
For­eign in­vest­ments in Ger­man life sci­ence com­pan­ies be­come sub­ject...
In re­sponse to the COV­ID-19 pan­dem­ic, Ger­many has widened the scope of its in­vest­ment con­trol to in­clude nu­mer­ous life sci­ence com­pan­ies. The amend­ments to the For­eign Trade and Pay­ments Or­din­ance ("AWV")...
CMS Ex­pert Guide to a Leg­al Roadmap to Can­nabis
04 May 20
EPO Board of ap­peal re­mits to ex­amin­ing di­vi­sion when pri­or art search...
In Mod­el de­term­in­a­tion sys­tem/Ac­cen­ture Glob­al Ser­vices Lim­ited (Case T-1159/15), the board of ap­peal finds that need to per­form a pri­or art search con­sti­tutes a spe­cial reas­on to re­mit the ap­peal ap­plic­a­tion...
Dec 2018
CMS Life Sci­ences & Health­care Sec­tor Group: An over­view...
30 Apr 20
USPTO finds an in­ven­tion cre­ated by an AI ma­chine is not pat­entable
The US Pat­ent and Trade Mark Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The USPTO ac­cep­ted the in­dic­a­tion...
1 May 2017
CMS, Nabarro and Olswang com­plete ground­break­ing mer­ger
Strength­en­ing CM­S' po­s­i­tion across Middle East and...
07 Apr 20
Coronavir­us and the food in­dustry: The UAE’s law to reg­u­late the stra­tegic...
Cor­rect as of 9am, 6th April. This art­icle is not be­ing main­tained. While the food and ag­ri­cul­tur­al sec­tor should in prin­ciple be less af­fected by the Cov­id-19 pan­dem­ic than oth­ers, la­bour short­ages,...
07/03/2016
CMS builds Is­lam­ic Fin­ance Prac­tice with new part­ner...
17 Mar 20
While doc­tors fight COV­ID-19 au­thor­it­ies battle fraud, price hikes...
In every coun­try hit by COV­ID-19, the dis­ease linked to the Coronavir­us, com­pet­i­tion and con­sumer pro­tec­tion au­thor­it­ies have been con­fron­ted with the vir­us's im­plic­a­tions. Gov­ern­ments, au­thor­it­ies and...
31 Jan 20
UK In­tel­lec­tu­al Prop­erty Of­fice finds that pat­ent law does not cater...
The UK In­tel­lec­tu­al Prop­erty Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The UKIPO ac­cep­ted the in­dic­a­tion...
26 Nov 19
Dubai Health­care City - Health and Pharma Over­view
Up un­til re­cently, there were no ex­pli­cit laws or au­thor­it­ies that dealt spe­cific­ally with pri­vacy and data pro­tec­tion in the UAE (ex­clud­ing the Dubai In­ter­na­tion­al Fin­an­cial Centre ('DI­FC') and Abu Dh­abi...